Category: Conferences

Search News
Categories
Archives
Immunotherapy for advanced bladder cancer

29th May 2020

An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.

Read more

Prof Manchanda awarded prestigious oration

16th December 2019

Professor Ranjit Manchanda delivered the Shyam Agarwal Memorial Oration at the Indian Society of Cancer Genetics Conference on 15 December.

Read more

ASH 2019

16th December 2019

Once again this December, researchers from Barts Cancer Institute (BCI)’s Centre for Haemato-Oncology made the trip to the American Society of Hematology Annual Meeting and Exposition, which this year took place in Orlando, Florida.

Read more

IBIS-II – new results from international breast cancer study

12th December 2019

The Queen Mary University of London professor leading an international breast cancer study says anastrozole – rather than tamoxifen – should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.

Read more

KEYNOTE-522: Immune therapy for breast cancer

30th September 2019

Results of an interim analysis from the KEYNOTE-522 trial have shown a treatment combination of immunotherapy plus chemotherapy to improve response rates in patients with early triple-negative breast cancer. Prof Peter Schmid presented the results at the ESMO Congress 2019 in Barcelona, Spain.

Read more

World Economic Forum, China

8th July 2019

Professor Fran Balkwill was selected as a high-level delegation to the World Economic Forum in Dalian, China, to discuss her work in cancer research. As one of three researchers selected by the European Research Council to attend, she participated in presentations, panel discussions and press conferences on the topic of ‘Tackling cancer from within – new perspectives’.

Read more

Search News
Categories
Archives